Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study-Reference-Cited by-同舟云学术

Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study

Published:2016-08 Issue:8 Volume:42 Page:1146-1152
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Zhang Y.,Mo M.,Li J.-w.,Zhou Y.,Wu J.,Yu K.-d.,Shen Z.-z.,Shao Z.-m.,Liu G.-y.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference18 articles.

1. Neoadjuvant therapy – what have we achieved in the last 20 years?;Huober;Breast Care,2011

2. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy;Navarro-Cecilia;Eur J Surg Oncol,2013

3. Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer;Shimazu;Surg Today,2011

4. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from national surgical adjuvant breast and bowel project B-18;Fisher;J Clin Oncol,1997

5. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy;Gianni;Clin Cancer Res,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Analysis of Breast Cancer in Patients with HER2/neu+, ER-, PR-: a Retrospective Cohort Study;Breast Cancer Management;2023-09

2. Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis;BJS Open;2022-05-02

3. The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population;Surgery;2020-12

4. Is invasion a necessary step for metastases in breast cancer?;Breast Cancer Research and Treatment;2018-01-20